期刊文献+

17例胆管癌的外科治疗及疗效分析

SURGICAL TREATMENT OF 17 CASES WITH CHOLANGIOCARCINOMA AND ANALYSIS OF ITS CURATIVE EFFECT
暂未订购
导出
摘要 [目的]分析胆管癌外科治疗的效果。[方法]从临床资料、手术方式和治疗结果等方面对近10年来17例行手术治疗的肝门部胆管癌进行回顾性研究。[结果]有14例获得随访,肿瘤切除组患者中位生存期为19个月;引流术组患者中位生存期为7.8个月。[结论]外科治疗是肝门部胆管癌的主要治疗方法,联合应用化、放疗可能改善患者的生活质量和生存期。 [ Objective ] To evaluate the efficacy of surgical therapy on cholangiocarcinoma. [ Methods] Chnical data, operative ways and therapeutical results of 17 patients with portal cholangiocarcinoma were reviewed from Jan. 1998 to Apr. 2007. [Results] 14 cases were followed up. The median survival time was 19 months in the patients with resection, and it was 7.8 months in the patients with drainage.[Conclusion] Surgery is the primary treatment of portal cholangiocarcinoma. Radiotherapy and chemotherapy may help to improve the quality of patients life and extend patients' life span.
作者 陈敦德
出处 《现代预防医学》 CAS 北大核心 2008年第13期2568-2569,共2页 Modern Preventive Medicine
关键词 胆管癌 治疗结果 外科手术 Cholangiocarcinoma Treatment outcome Surgery
  • 相关文献

参考文献8

  • 1郑树国,何振平,董家鸿,王曙光,别平,蔡景修,韩本立,李智华,黄志强,刘永雄.肝门部胆管癌外科治疗20年经验回顾[J].中国普通外科杂志,2001,10(1):6-10. 被引量:38
  • 2Lillemoe KD.Surgery for hilar cholangioearcinoma [J]. J Hepatobiliary Pan-erent Sury, 2000, 7 (2): 115-121.
  • 3孟翔飞,周宁新,肖梅,李铸,丁振昊,黄志强.肝门部胆管癌病理特征与术后随访结果分析(附113例报告)[J].消化外科,2006,5(1):49-51. 被引量:12
  • 4Tsuzuki T. Ueda M, Kuramachi S. et al. Carcinoma of the main hepatic duet unction: indications, operative morbidity and mortality, and long term survival.Surgery, 1990, 108 (3): 495-501.
  • 5Tsao Ji, Nimura Y, Kamiya J, et al. Management of hilar cholangioearci-noma: cmparlson of an American and Japanese experience [J]. Ann Surg, 2000, 232 (2): 166-174.
  • 6Kondo S, Hirano S, Ambo Y, et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins[J]. Ann Surg, 2004, 240 (1): 95-101.
  • 7王大东,黄志强,周宁新,陈乐真.神经细胞粘附分子在胆管癌神经浸润转移中的作用[J].中华实验外科杂志,2000,17(2):171-172. 被引量:19
  • 8Hayes JK Jr, sapozink MD, Miller FJ.definitive radiation therapy in bile duct carcinoma[J]. Int J Radiat Oncol Biol Phys, 1988, 15 (6): 735-744.

二级参考文献19

  • 1王学铭.钙依粘附蛋白和神经细胞粘附分子的结构与功能[J].生命的化学,1995,15(2):18-20. 被引量:7
  • 2王曙光,韩本立,陈意生,彭志明,贺光友.胆管癌转移途径的病理学研究[J].中华外科杂志,1996,34(6):352-354. 被引量:38
  • 3何振平.肝门部胆管癌的围手术期处理[J].中国实用外科杂志,1997,18(6):373-373.
  • 4Seiji K,Hiroshi I,Akira K,et al.Results of surgical resection for patients with hilar bile duct cancer[J].Ann Surg,2003,238(1):84-92.
  • 5Kondo S,Hirano S,Ambo Y,et al.Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins[J].Ann Surg,2004,240(1):95-101.
  • 6Ogura Y,Kawarada Y.Surgical strategies for carcinoma of the hepatic duct confluence[J].Br J Surg,1998,85(1):20-24.
  • 7Kosuge T,Yamamoto J,Shimada K,et al.Improved surgical resultsfor hilar cholangiocarcinoma with procedures including major hepaticresection.Ann Surg,1999,230(5):663-671.
  • 8Tojima Y,Nagino M,Ebata T,et al.Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholaniocarcinoma[J].Ann Surg,2003,237(2):201-207.
  • 9Klempnauer J,Ridder G J,Werner M,et al.What constitutes long term survival after surgery for hilar cholangiocarcinoma[J]? Cancer,1997,79(1):26-34.
  • 10Kitagawa Y,Nagino M,Kamiya J,et al.Lymph node metastasis from hilar cholangiocarcinoma:audit of 110 patients hho underwent regional and paraaortic node dissection[J].Ann Surg,2001,233(3):385-392.

共引文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部